Cardiovascular Outcome Risks in Patients With Erectile Dysfunction Co-Prescribed a Phosphodiesterase Type 5 Inhibitor (PDE5i) and a Nitrate: A Retrospective Observational Study Using Electronic Health Record Data in the United States-Reference-Cited by-同舟云学术

Cardiovascular Outcome Risks in Patients With Erectile Dysfunction Co-Prescribed a Phosphodiesterase Type 5 Inhibitor (PDE5i) and a Nitrate: A Retrospective Observational Study Using Electronic Health Record Data in the United States

Published:2021-09 Issue:9 Volume:18 Page:1511-1523
ISSN:1743-6095
Container-title:The Journal of Sexual Medicine
language:en
Short-container-title:The Journal of Sexual Medicine

Author:

Nunes Anthony P.,Seeger John D.,Stewart Andrew,Gupta Alankar,McGraw Thomas

Funder

Sanofi

Publisher

Elsevier BV

Subject

Urology,Reproductive Medicine,Endocrinology,Endocrinology, Diabetes and Metabolism,Psychiatry and Mental health

Reference28 articles.

1. Urologic diseases in America project. Predictors and prevalence of erectile dysfunction in a racially diverse population;Saigal;Arch Intern Med,2006

2. Erectile dysfunction and the cardiovascular patient: Endothelial dysfunction is the common denominator;Solomon;Heart,2003

3. Erectile dysfunction and cardiovascular disease: Efficacy and safety of phosphodiesterase type 5 inhibitors in men with both conditions;Nehra;Mayo Clin Proc,2009

4. The erectile dysfunction as a marker of cardiovascular disease: A review;Diaconu;Acta Cardiologica,2020

5. Prevalence and risk factors for erectile dysfunction in the US;Selvin;Am J Med,2007

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term effects of phosphodiesterase-5 inhibitors on cardiovascular outcomes and death: a systematic review and meta-analysis;European Heart Journal - Cardiovascular Pharmacotherapy;2024-07-30

2. Proceedings of PRINCETON IV: PDE5 inhibitors and cardiac health symposium;Sexual Medicine Reviews;2024-06-27

3. Reply;Journal of the American College of Cardiology;2024-06

4. Nitrates and Phosphodiesterase-5 Inhibitors;Journal of the American College of Cardiology;2024-06

5. Erectile Dysfunction and Coronary Artery Disease;Journal of the American College of Cardiology;2024-01